Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marksteiner

Showing results (261-270 of 315) with videos related to

Pageof 32
Sort By:
Neuroreport|July 17, 2004
Basal forebrain atrophy is a distinctive pattern in dementia with Lewy bodiesChristian Brenneis, Gregor K Wenning, Karl E Egger, et al.
Frontiers in Aging Neuroscience|March 2, 2026
Plasma phospho-tau 217 outperforms plasma phospho-tau 181 analyzed with Lumipulse in detecting Alzheimer's dementia in a real-world memory clinic populationMichaela Defrancesco, Elke R Gizewski, Ruth Steiger, et al.
Deutsche Medizinische Wochenschrift (1946)|February 22, 2008
[Mild cognitive impairment with predictors of rapid decline]H Förstl, H Bickel, L Frölich, et al.
Journal of Autism and Developmental Disorders|November 3, 2012
Brief report: CANTAB performance and brain structure in pediatric patients with Asperger syndromeLiane Kaufmann, Sibylle Zotter, Silvia Pixner, et al.
Stem Cell Research & Therapy|February 25, 2021
Myogenic progenitor cell transplantation for muscle regeneration following hindlimb ischemia and reperfusionFranka Messner, Marco Thurner, Jule Müller, et al.
Neuroscience|December 1, 1994
Molecular characterization of immunoreactivities of peptides derived from chromogranin A (GE-25) and from secretogranin II (secretoneurin) in human and bovine cerebrospinal fluidR Kirchmair, A Benzer, J Troger, et al.
Wiener Klinische Wochenschrift|September 5, 2025
Resources of Austrian hospital-based departments of neurology and psychiatry for new amyloid-antibody therapies in early Alzheimer dementia : A survey of the Austrian Alzheimer SocietyGerhard Ransmayr, Edith Eicher, Jürgen Mraczansky, et al.
Journal of the International Neuropsychological Society : JINS|October 22, 2011
Influence of serotonin transporter genotype and catechol-O-methyltransferase Val158Met polymorphism on recognition of emotional facesMichaela Defrancesco, Harald Niederstätter, Walther Parson, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
L-type calcium channel CaV 1.2 in transgenic mice overexpressing human AbetaPP751 with the London (V717I) and Swedish (K670M/N671L) mutationsMichael Willis, Walter A Kaufmann, Georg Wietzorrek, et al.
Neurobiology of Aging|April 28, 2009
Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's diseaseJosef Marksteiner, Georg Kemmler, Elisabeth M Weiss, et al.
Pageof 32

Showing results (261-270 of 315) with videos related to

Sort By:
Pageof 32
Neuroreport|July 17, 2004
Basal forebrain atrophy is a distinctive pattern in dementia with Lewy bodiesChristian Brenneis, Gregor K Wenning, Karl E Egger, et al.
Frontiers in Aging Neuroscience|March 2, 2026
Plasma phospho-tau 217 outperforms plasma phospho-tau 181 analyzed with Lumipulse in detecting Alzheimer's dementia in a real-world memory clinic populationMichaela Defrancesco, Elke R Gizewski, Ruth Steiger, et al.
Deutsche Medizinische Wochenschrift (1946)|February 22, 2008
[Mild cognitive impairment with predictors of rapid decline]H Förstl, H Bickel, L Frölich, et al.
Journal of Autism and Developmental Disorders|November 3, 2012
Brief report: CANTAB performance and brain structure in pediatric patients with Asperger syndromeLiane Kaufmann, Sibylle Zotter, Silvia Pixner, et al.
Stem Cell Research & Therapy|February 25, 2021
Myogenic progenitor cell transplantation for muscle regeneration following hindlimb ischemia and reperfusionFranka Messner, Marco Thurner, Jule Müller, et al.
Neuroscience|December 1, 1994
Molecular characterization of immunoreactivities of peptides derived from chromogranin A (GE-25) and from secretogranin II (secretoneurin) in human and bovine cerebrospinal fluidR Kirchmair, A Benzer, J Troger, et al.
Wiener Klinische Wochenschrift|September 5, 2025
Resources of Austrian hospital-based departments of neurology and psychiatry for new amyloid-antibody therapies in early Alzheimer dementia : A survey of the Austrian Alzheimer SocietyGerhard Ransmayr, Edith Eicher, Jürgen Mraczansky, et al.
Journal of the International Neuropsychological Society : JINS|October 22, 2011
Influence of serotonin transporter genotype and catechol-O-methyltransferase Val158Met polymorphism on recognition of emotional facesMichaela Defrancesco, Harald Niederstätter, Walther Parson, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
L-type calcium channel CaV 1.2 in transgenic mice overexpressing human AbetaPP751 with the London (V717I) and Swedish (K670M/N671L) mutationsMichael Willis, Walter A Kaufmann, Georg Wietzorrek, et al.
Neurobiology of Aging|April 28, 2009
Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's diseaseJosef Marksteiner, Georg Kemmler, Elisabeth M Weiss, et al.
Pageof 32